NHI:NYE-National Health Investors Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 61.82

Change

+0.25 (+0.41)%

Market Cap

USD 2.83B

Volume

0.13M

Analyst Target

USD 61.22
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

National Health Investors Inc is a real estate investment trust. The Company is engaged in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing & medical investments.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 55.76B
VTR Ventas Inc

N/A

USD 17.31B
DOC Healthpeak Properties Inc

N/A

USD 12.76B
OHI Omega Healthcare Investors Inc

N/A

USD 7.67B
HR Healthcare Realty Trust Incorp..

N/A

USD 5.39B
CTRE CareTrust REIT Inc.

N/A

USD 3.28B
MPW Medical Properties Trust Inc

N/A

USD 2.43B
AHR American Healthcare REIT Inc

N/A

USD 1.65B
LTC LTC Properties Inc

N/A

USD 1.38B
CHCT Community Healthcare Trust Inc

N/A

USD 0.71B

ETFs Containing NHI

SRET Global X SuperDividend® .. 4.28 % 0.59 %

N/A

USD 0.21B
DIV Global X SuperDividend U... 2.24 % 0.46 %

N/A

USD 0.61B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.69% 94% A 79% B-
Dividend Return 1.61% 29% F 75% C
Total Return 12.30% 94% A 82% B
Trailing 12 Months  
Capital Gain 22.08% 75% C 72% C
Dividend Return 8.89% 87% B+ 88% B+
Total Return 30.96% 75% C 78% C+
Trailing 5 Years  
Capital Gain -21.30% 58% F 23% F
Dividend Return 24.78% 58% F 80% B-
Total Return 3.48% 58% F 30% F
Average Annual (5 Year Horizon)  
Capital Gain -8.01% 31% F 13% F
Dividend Return -1.95% 38% F 20% F
Total Return 6.07% 69% C- 87% B+
Risk Return Profile  
Volatility (Standard Deviation) 19.54% 38% F 57% F
Risk Adjusted Return -9.96% 54% F 22% F
Market Capitalization 2.83B 59% D- 67% D+

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.40 87% 44%
Price/Book Ratio 2.03 38% 41%
Price / Cash Flow Ratio 13.80 29% 27%
Price/Free Cash Flow Ratio 14.08 63% 28%
Management Effectiveness  
Return on Equity 10.48% 94% 60%
Return on Invested Capital -2.29% 6% 19%
Return on Assets 4.48% 88% 68%
Debt to Equity Ratio 90.52% 59% 40%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.